Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Operational Other
confidence 75%
filed 2026-07-02
EX-99.1
This is a monthly business update disclosing multiple operational developments: completion of the Houdini Swap acquisition (closed June 1, 2026), integration with Jumper (announced June 18, 2026), treasury management activities (CAD $5.75 million debt settlement via SOL sales), and wind-down of non-Solana validators. While the Houdini Swap acquisition itself could be classified as `ma_activity`, the exhibit is framed as a comprehensive operational update covering acquisition integration, product launches, and strategic business decisions rather than a discrete M&A announcement. The material nature of the acquisition completion and the integration milestone, combined with treasury actions and operational restructuring, makes this material to investors assessing the company's strategic direction and operational execution.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-07-02
EX-99.1
The press release discloses multiple equity issuances and conversions during Q2 2026 that collectively increase shareholder equity by $3.8 million, including: conversion of $2.1 million in related-party loans and convertible debentures into 2,192 Series B Convertible Preferred Shares; conversion of 1,351 Series A Convertible Preferred Shares into ~1.5 million common shares; issuance of 257,638 common shares to settle accrued interest; and exercise of 256,410 warrants. These transactions involve significant dilution to existing shareholders through debt-to-equity conversions and warrant exercises, characteristic of dilutive capital restructuring at a small-cap issuer.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-02
EX-99.1
Peter Ballantyne Cree Nation has withdrawn its judicial review application against the Phoenix ISR uranium mine's Environmental Assessment approval and formally provided consent and support for the Wheeler River Project. This removes a material legal/regulatory obstacle to the project's development and represents a significant operational milestone for Denison's flagship asset, which is in early construction phase with first production targeted for 2028.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-02
Item 1.01
Sky Quarry entered into a Conversion and Exchange Agreement on June 29, 2026, converting $3,985,000 in merchant cash advance obligations into a new promissory note bearing 8% interest with escalating weekly payments and restrictive covenants, including a personal guarantee by the CEO. This restructuring creates a new direct financial obligation with significant repayment obligations and restrictions on asset sales and receivables pledging.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-02
Item 1.02
Sky Quarry terminated a material definitive agreement as disclosed in Item 1.02, which incorporates Item 1.01 by reference. The termination of this material agreement signals a material change in the registrant's strategic position or transaction arrangement.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-02
EX-99.1
This is a press release announcing NIO's June and Q2 2026 delivery results, a key operational metric for an automotive manufacturer. The disclosure reports 40,597 vehicles delivered in June (up 62.9% YoY) and 107,658 in Q2 (up 49.4% YoY), along with cumulative deliveries of 1,188,715 units. While not a full earnings release with GAAP financials, delivery updates are material operational disclosures that directly inform investor assessment of the company's performance and market position, particularly for EV manufacturers where unit sales are a primary value driver.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-02
Item 1.01
Elicio Therapeutics entered into a Securities Purchase Agreement on July 1, 2026, to issue 4,380,313 shares of common stock at $3.43 per share in a registered direct offering, generating approximately $15 million in gross proceeds. The offering is being made pursuant to an effective Form S-3 registration statement, with proceeds intended to fund clinical development and working capital.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-07-02
EX-99.1
GFL Environmental announced a quarterly cash dividend of US$0.0169 per share declared by the Board of Directors, payable July 31, 2026 to shareholders of record on July 13, 2026. This is a routine but material capital distribution to shareholders that would affect investor assessment of the company's capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-07-02
EX-99.1
The exhibit discloses the grant of 7,025,385 restricted share units (RSUs) to 649 employees on July 1, 2026, pursuant to the 2020 Share Incentive Plan. This is a compensatory arrangement involving equity grants with specified vesting schedules, clawback mechanisms, and performance terms. Although the grantees are employees rather than named executives, the disclosure of a material equity grant program with detailed vesting conditions and forfeiture provisions falls squarely within executive compensation disclosure obligations. The grant is material to investors as it represents a significant dilutive equity issuance affecting shareholder value.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-02
The filing announces the appointment of Mr. Botao Shi as interim chief financial officer of Concord Medical, effective June 30, 2026. While the filing also discloses the resignation of the prior CFO, Mr. Wei Jiang, the principal disclosed action is the appointment of a new CFO to fill that role. The appointment of a CFO is a material executive change affecting the registrant's financial leadership and would affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-02
Item 1.01
Alliance Resource Partners completed a $206.2 million acquisition of general partner and limited partner interests in AllDale Minerals III and IV on July 1, 2026, materially expanding ARLP's oil & gas royalty acreage to approximately 115,680 net royalty acres, including over 44,770 acres in the Permian Basin.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-02
Item 2.03
Alliance Resource Partners issued a new $150 million term loan to Alliance Minerals, LLC (a wholly owned subsidiary) to fund the acquisition, creating a material direct financial obligation.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-02
Item 3.02
The filing discloses an unregistered sale of 47,747 common shares of beneficial interest for $721,943.51 pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D. This is a classic private placement of equity securities, which is material to investors as it represents dilution and capital raising activity typical of BDCs.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-02
EX-99.1
The disclosure reports a rock mass movement at the Barnat open pit of the Canadian Malartic complex on July 1, 2026, resulting in temporary suspension of mining operations. While the company states there were no injuries, equipment damage, or environmental impact, the event is material because it reduces expected full-year 2026 production by 60,000–80,000 ounces of gold (moving guidance to the lower end of the range) and is expected to reduce production in 2027 and 2028 by up to 150,000 ounces per year. This is an operational disruption with significant production consequences that would affect a reasonable investor's assessment of the registrant's near-term and medium-term output and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-02
Item 2.02
EACO Corporation issued a press release on July 1, 2026 announcing third-quarter fiscal 2026 financial results, including net sales of $142.4 million (27.8% increase YoY), net income of $13.6 million (42.6% increase YoY), and basic EPS of $2.79 (43.1% increase YoY). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard disclosure mechanism for quarterly earnings releases.
View raw filing on EDGAR →
8-K
Cybersecurity Incident
confidence 98%
filed 2026-07-02
Item 1.05
AdaptHealth Corp. disclosed a material cybersecurity incident under Item 1.05 involving unauthorized access to cloud-based systems and exfiltration of sensitive data including patient personally identifiable information and protected health information. The Company explicitly determined the incident material on June 27, 2026, due to "the nature and potential volume of the data that is at risk." The incident resulted from a social engineering attack compromising a third-party contractor's user session, and while contained, the full scope and financial impact remain under investigation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-02
Item 5.07
Barinthus Biotherapeutics held its 2026 Annual General Meeting on July 2, 2026, with shareholders approving all seven ordinary resolutions, including re-election of directors Karen T. Dawes and Anne M. Phillips, re-appointment and ratification of PricewaterhouseCoopers LLP as auditors, authorization of auditor remuneration, receipt of annual accounts and dividend decision, and advisory approval of the directors' compensation report.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-02
Item 8.01
Barinthus Biotherapeutics received notice from Nasdaq on June 30, 2026, granting an additional 180-calendar-day compliance period (until December 28, 2026) to regain compliance with the $1.00 minimum bid price requirement after its ADSs were transferred from the Nasdaq Global Market to the Nasdaq Capital Market. If compliance is not regained by the deadline, Nasdaq will issue notice of delisting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 75%
filed 2026-07-02
Item 8.01
The filing discloses the commencement and adjournment of the 2026 Annual Meeting of Stockholders, with preliminary voting reports indicating all proposals have received necessary stockholder support for approval. While the meeting was adjourned pending Nasdaq's review of the initial listing application (specifically regarding Proposal 1 on conversion of preferred stock), the core disclosure centers on stockholder voting results and the reconvened meeting scheduled for July 20, 2026. This is material as it relates to shareholder approval of significant corporate actions, particularly the conversion of Series A and Series B Non-Voting Convertible Preferred Stock into common stock.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-02
Item 8.01
MetaVia Inc. entered into an At The Market (ATM) Offering Agreement on November 6, 2025, and filed a prospectus supplement on July 2, 2026, to offer and sell up to $4,000,000 of common stock shares through Ladenburg Thalmann. This is a classic dilutive equity issuance under Rule 415(a)(4), which creates potential shareholder dilution and is material to investors assessing capital structure and ownership stakes.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-07-02
Item 1.01
The filing discloses an amendment to a Registration Rights Agreement with holders of 50.1% or more of Registrable Securities, extending the Filing Date deadline to 30 calendar days after the Final Closing Date (on or before July 17, 2026). This is a material amendment to a capital-related agreement affecting registration obligations and timing, but does not fit the specific categories of debt issuance, dilutive issuance, or M&A activity. It is clearly financial in nature and material to investors monitoring the company's capital structure and registration timeline.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-07-02
Item 1.01
W. P. Carey consummated a public offering of $350 million in 5.200% Senior Notes due 2036 on July 2, 2026. This is a direct creation of a new financial obligation governed by an indenture with specified terms, interest rate, and maturity date. The company intends to use proceeds to repay existing debt and fund general corporate purposes, which is typical debt issuance disclosure under Item 1.01.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-02
EX-99.1
This exhibit presents unaudited pro forma consolidated financial statements reflecting the disposition of certain operating subsidiaries and related business assets for nominal consideration of RMB 1. The document explicitly states the pro forma balance sheet and statement of operations are prepared "as if the Disposition had been consummated" and "as if the Disposition had occurred on January 1, 2025." This is a material disposition/divestiture event that substantially reduces the Company's asset base and operational scope, eliminating all revenue and operating expenses from the disposed subsidiaries. The transaction materially affects the registrant's financial position and future operations.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-07-02
Item 4.01
The filing discloses the dismissal of Ernst & Young LLP as the Company's independent registered public accounting firm effective June 29, 2026, and the concurrent engagement of KPMG LLP as the new auditor. This is a classic auditor change event under Item 4.01. The disclosure confirms no disagreements or reportable events with the departing auditor, and no prior consultations with the incoming auditor on accounting matters, indicating a routine transition rather than one driven by audit disputes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-02
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Alumis Inc.'s 2026 Annual Meeting of Stockholders held on June 30, 2026. The filing presents voting results for two proposals: election of three Class II directors (James B. Tananbaum, Lynn Tetrault, and Zhengbin Yao) and ratification of PricewaterhouseCoopers LLP as independent auditor, with detailed vote tallies for each matter. Shareholder votes on director elections and auditor ratification are material governance events affecting investor assessment of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 96%
filed 2026-07-02
Item 2.03
Kite Realty Group's operating partnership issued $345 million aggregate principal amount of 3.25% Exchangeable Senior Notes due 2032 on July 2, 2026, pursuant to an Indenture with U.S. Bank Trust Company as trustee. The notes are senior unsecured obligations exchangeable into approximately 11.9 million common shares, with net proceeds of approximately $335.7 million used for debt repayment and share repurchases.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-02
Item 3.02
The operating partnership issued $345 million of exchangeable senior notes to qualified institutional buyers under Rule 144A as an unregistered private placement, with the notes exchangeable into approximately 11.9 million common shares at an initial exchange rate of 28.2466 shares per $1,000 principal.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-02
Item 5.02
The disclosure centers on the Company's adoption of the 2026 Performance Equity Plan on July 1, 2026, which reserves 33.6 million shares for stock-based awards to employees, executives, and directors. The Board intends to grant performance awards under the Plan to executive officers and named executive officers as incentive compensation. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an executive departure or appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-07-02
Item 5.07
Gold Resource Corporation shareholders approved the Arrangement Agreement and Plan of Merger with Goldgroup Mining Inc. at a special meeting held on July 2, 2026, with 96,312,452 votes in favor and 4,681,241 votes against. The merger will result in Gold Resource becoming a wholly owned subsidiary of Goldgroup.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 88%
filed 2026-07-02
Item 1.01
Terra Property Trust completed an exchange offer on June 30, 2026, resulting in issuance of $27,156,250 aggregate principal of new 11.00% Senior Secured Notes due July 1, 2027, and entered into a $25 million term loan agreement with Strategic Yieldco on June 29, 2026. Both transactions represent material creation of new direct financial obligations affecting the registrant's capital structure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-02
Item 2.02
MV Oil Trust announced its final quarterly distribution of $6,829,206 ($0.593844 per unit) payable July 24, 2026.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-02
Item 3.01
MV Oil Trust's net profits interest terminated on June 30, 2026, triggering dissolution of the Trust. The trustee notified the NYSE on July 2, 2026 of the Trust's intention to voluntarily withdraw listing, with delisting expected prior to market open on July 27, 2026, followed by Form 15 deregistration.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-02
EX-99.1
This is an at-the-market (ATM) sales agreement dated July 2, 2026, under which NervGen Pharma Corp. authorizes Leerink Partners LLC to sell up to US$50,000,000 of common shares on an ongoing basis. The agreement explicitly permits sales "at market prices" through Nasdaq and other U.S. trading venues (Section 3), with the Company retaining discretion to issue Placement Notices controlling timing and volume. This is a classic dilutive equity issuance arrangement that would materially affect shareholder interests through potential share dilution.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-02
Item 1.01
On June 29, 2026, Chiron Real Estate completed the sale of seven inpatient rehabilitation hospital properties for $217.0 million aggregate purchase price, while retaining a 15% ownership interest in the purchasing joint venture. The transaction resulted in an estimated gain on sale of approximately $70.7 million and materially affects the Company's asset base, operations, and financial position.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-02
Item 7.01
Duke Energy Carolinas reached a partial settlement with the North Carolina Public Staff on a rate case filed November 20, 2025, resolving certain operating costs, capital expenditures, and accounting adjustments while leaving major issues (ROE, capital structure, MYRP capital program, storm recovery) for litigation. The settlement results in a $10 million pre-tax accounting charge in Q2 2026 and reduces the company's requested revenue increase from $1,002 million to $556 million. This is a material regulatory milestone affecting the company's operational and financial trajectory, but does not fit neatly into financial categories (not a restatement, impairment, or debt event) and is best classified as a significant operational/regulatory development.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-07-02
Item 5.03
The Company effected a 1-for-20 reverse stock split through an amendment to its Certificate of Incorporation filed with Delaware on July 2, 2026, materially modifying the rights of security holders.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-07-02
EX-99.1
The exhibit is a formal notice from Grupo Financiero Galicia announcing the payment of the first installment of cash dividends in the amount of Ps. 13,333,257,333.33, approved by the Ordinary Shareholders' Meeting on April 28, 2026, with payment to shareholders registered as of July 6, 2026, effective July 13, 2026. This is a material dividend distribution event that would affect investor assessment of capital returns.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-07-02
EX-99.1
The exhibit is a formal notice of cash dividend payment by Grupo Financiero Galicia S.A. declaring a total dividend of Ps. 39,999,772,000 payable in three equal installments beginning July 1, 2026, at Ps. 8.30084132575628 per share. This is a material distribution to shareholders approved by the Board on June 30, 2026, in compliance with the April 28, 2026 shareholders' meeting resolution.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-02
EX-99.1
Itaú Unibanco won a competitive bidding process to renew a five-year contract providing payment and payroll services to approximately 670,000 employees and suppliers of the State of Minas Gerais, with a total investment of BRL 2.188 billion recorded as an intangible asset. This is a material operational/commercial milestone — a significant contract renewal with a large government entity — but does not fit the specific event categories (not M&A, not a financial obligation in the debt sense, not a restructuring). The operational domain is clear, making `operational_other` more appropriate than `other_material`.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-02
EX-99.1
The press release announces the successful completion of IperionX's acquisition of the Camden critical mineral, property, and infrastructure assets located adjacent to the Titan Project in Tennessee. This is a material acquisition that consolidates and expands the company's landholdings and mineral rights, combining ultra-high-grade surface stockpiles with established infrastructure and pre-stripped mineralization. The deal is explicitly described as "transformational" and "strategically important" to the company's development pathway.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-07-02
Item 1.01
The filing discloses Amendment No. 7 to the CEO's employment agreement, which extends the contract term and, more substantively, approves salary increases for Selwyn Joffe from $828,256 to $902,799 (effective June 26, 2026) and further to $984,050 (effective April 1, 2027). While the amendment also extends the employment term, the principal disclosed action centers on the compensatory arrangement—the salary increases approved by the Board and Compensation Committee. This is a material executive compensation disclosure under Item 1.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-02
Item 1.01
FTAI Infrastructure Inc. entered into a Bridge Loan Credit Agreement on July 1, 2026, creating a new $230.0 million secured debt facility. The bridge loan was used to repay maturing Taxable Series 2024B Bonds and fund debt service reserves, representing a material new financing arrangement affecting the registrant's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Cybersecurity Incident
confidence 98%
filed 2026-07-02
Item 1.05
The filing explicitly discloses a material cybersecurity incident under Item 1.05: a ransomware attack on a third-party law firm resulted in unauthorized access to sensitive Company-related borrower data including names, dates of birth, addresses, and Social Security numbers. The Company determined the incident material on June 29, 2026 "in light of the volume and sensitivity of the information involved," triggering mandatory disclosure and notification obligations under federal and state law.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 90%
filed 2026-07-02
Item 1.01
BridgeBio entered into an Investment Agreement on July 1, 2026, under which Sixth Street Partners and HealthCare Royalty (a KKR affiliate) purchased $1 billion in Series A Cumulative Convertible Participating Preferred Stock, convertible into approximately 6.78 million common shares at an initial conversion price of $137.79 per share. This substantial private placement, relying on Section 4(a)(2) exemption, materially dilutes existing shareholders' ownership and voting power while strengthening the company's balance sheet.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-02
Item 5.02
The filing discloses both a director departure (David Sambur's resignation effective July 2, 2026) and a director appointment (Christine Duffy's appointment to fill the vacancy). While both events occur, the principal disclosed action centers on the appointment of Ms. Duffy to the board, with her qualifications, compensation terms, and indemnification agreement detailed. The departure is presented as a mechanical consequence of Apollo Investors' reduced designation rights following their public offering. The appointment of a qualified director with significant hospitality industry experience is the substantive event requiring investor attention.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-02
Item 1.01
Bank7 Corp. entered into a definitive Stock Purchase Agreement on July 1, 2026, to acquire approximately 71% of Century Financial Services Corporation for $68.0 million in cash, creating a combined organization with approximately $3.4 billion in total assets. The transaction is subject to court approval and regulatory conditions and represents a material, franchise-enhancing acquisition extending Bank7's geographic footprint into New Mexico.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-02
Item 1.01
T. Rowe Price OHA Select Private Credit Fund entered into an Indenture on July 2, 2026, relating to the issuance of $400 million in aggregate principal amount of 6.500% Notes due 2031, with net proceeds of approximately $391.4 million to be used for investments, debt reduction, and general corporate purposes.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-02
Item 5.02
The filing discloses the departure of Cortney Caudill as Senior Vice President, Chief Operating Officer effective June 30, 2026. The principal disclosed action is a named executive officer leaving her role. While the filing mentions "an update to its senior management structure," the substantive disclosure centers on Ms. Caudill's departure, making this an exec_departure event. The COO position is material to investor assessment of company leadership.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-02
EX-99.1
This press release announces a clinical development milestone: the first patients dosed in a Phase 1/2a trial of MP0712, a Radio-DARPin candidate targeting DLL3 in small cell lung cancer and other neuroendocrine tumors. The disclosure is a material operational/clinical event for a clinical-stage biotech company, marking progress in a lead program under a strategic partnership with Orano Med. While not a discrete M&A transaction, executive change, or financial event, it represents a significant advancement in the company's pipeline that would affect a reasonable investor's assessment of development progress and value.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-02
Item 7.01
PennantPark Investment Corporation announced its monthly distribution of $0.08 per share for July 2026, comprised of a $0.04 base dividend and $0.04 supplemental dividend, payable on August 3, 2026. This is a routine but material disclosure of a dividend distribution to shareholders, which is a standard event for a business development company and would affect investor assessment of capital returns.
View raw filing on EDGAR →